Wellstar Recognized for Expert Patient Care

Quick history lesson: In the 1990s, U.S. doctors adopted the prostate-specific antigen test—or PSA—to identify prostate cancer early, when it’s more treatable. While the PSA helped more men get diagnosed, concern was raised over the risks versus benefits of biopsies, procedures and treatment. In response, the U.S. Preventive Services Task Force gave a controversial recommendation against routine screening with PSA in 2012.

But with new evidence from a variety of credible studies, they changed their recommendation in 2017. The current Task Force recommendation focuses on men having a conversation with their doctors about their risk for prostate cancer and the risks and benefits of screening.

Why did the guidelines change?

Prostate cancer is the most common cancer diagnosed in males after skin cancer. The American Cancer Society projects that there will be more than twice as many prostate cancer cases diagnosed in men as lung cancer this year.

“The prevalence of the disease cannot be ignored,” said Dr. Jeffrey Tharp, a primary care physician and chief medicine division officer for Wellstar Medical Group. “Early-stage prostate cancer has higher survivability than prostate cancer diagnosed in later stages.”

Dr. Tharp pointed out that while guidelines have changed, so have the way doctors diagnose and treat prostate cancer. An elevated PSA does not automatically mean a cancer diagnosis. And when cancer is diagnosed, some care options have no side effects.

Read on to learn:

• Who should have a conversation with their doctor about prostate cancer screening, and when
• Who is at higher risk
• How the reason that’s holding some men back has changed
• What is a PSA and why having them at regular intervals is important
• Care options for prostate cancer

Leading healthcare institutions in the Central Savannah River Area (CSRA) have joined forces to enhance collaboration and address critical healthcare needs in the region. The inaugural meeting of the CSRA Healthcare Leadership Council convened Dec. 12, 2023.

Comprising the top executives from the area’s foremost hospitals, the council includes Ralph Turner, president of Wellstar MCG Health Medical Center; Joanna Conley, chief executive officer of Doctors Hospital; Lily Henson, chief executive officer of Piedmont Augusta; and Robin Jackson, medical center director of the VA Augusta Health Care System.

Wellstar MCG Health’s Ralph Turner emphasized the significance of collaboration among healthcare leaders. “Sometimes there’s a focus on competition among hospitals, but we have a common goal of wanting to take care of the people in our community.”

Joanna Conley added: “At Doctors Hospital, our mission is that, above all else, we are committed to the care and improvement of human life. By convening regularly, we can strengthen our partnership and elevate the level of care across the CSRA.”

Robin Jackson of VA Augusta Health Care System said the council is about sharing resources, knowledge and best practices. “Quality healthcare doesn’t happen in isolation. It starts with partnership. The communication and collaboration coming out of the CSRA Healthcare Leadership Council will only strengthen the quality of care we deliver to local veterans and the wider community.”

The group’s monthly meetings will focus on recurring topics such as community health and emergency preparedness for the area.

“Piedmont Augsuta is creating real change across Georgia, in part through partnerships that empower our communities with education and access to seamless, hassle-free, high-quality care,” said Lily Henson. “By embracing the future and exemplifying teamwork and connections, we can make a positive difference in every life we touch.”

The council’s monthly meetings will rotate among participating facilities, fostering inclusivity and equitable engagement. These gatherings will serve as forums for discussing pressing healthcare issues and identifying collaborative opportunities to enhance patient care and community well-being.